Literature DB >> 9020361

MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.

N L Malinin1, M P Boldin, A V Kovalenko, D Wallach.   

Abstract

Several members of the tumour-necrosis/nerve-growth factor (TNF/NGF) receptor family activate the transcription factor NF-kappaB through a common adaptor protein, Traf2 (refs 1-5), whereas the interleukin 1 type-I receptor activates NF-kappaB independently of Traf2 (ref. 4). We have now cloned a new protein kinase, NIK, which binds to Traf2 and stimulates NF-kappaB activity. This kinase shares sequence similarity with several MAPKK kinases. Expression in cells of kinase-deficient NIK mutants fails to stimulate NF-kappaB and blocks its induction by TNF, by either of the two TNF receptors or by the receptor CD95 (Fas/Apo-1), and by TRADD, RIP and MORT1/FADD, which are adaptor proteins that bind to these receptors. It also blocked NF-kappaB induction by interleukin-1. Our findings indicate that NIK participates in an NF-kappaB-inducing signalling cascade common to receptors of the TNF/NGF family and to the interleukin-1 type-I receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020361     DOI: 10.1038/385540a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  289 in total

Review 1.  Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha.

Authors:  R T Hay; L Vuillard; J M Desterro; M S Rodriguez
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-09-29       Impact factor: 6.237

2.  Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.

Authors:  A Finch; W Davis; W G Carter; J Saklatvala
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

3.  The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.

Authors:  K M Izumi; E D Cahir McFarland; A T Ting; E A Riley; B Seed; E D Kieff
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

4.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.

Authors:  E Kopp; R Medzhitov; J Carothers; C Xiao; I Douglas; C A Janeway; S Ghosh
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

6.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 7.  Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.

Authors:  E Zandi; M Karin
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

8.  Regulation of CD30 antigen expression and its potential significance for human disease.

Authors:  M E Kadin
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 9.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

10.  Activation of nuclear factor kappaB as a target for anti-inflammatory therapy.

Authors:  S Schreiber
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.